NE alterations independently arose across several patients within several predominant signaling pathways known to contribute to tumor progression including the PI3K pathway, RTK/RAS pathway, apoptosis, angiogenesis, and junction assembly pathways (Fig. 6a). The gene discussed is PIK3CA; the disease is neoplasm.